Researchers at SUNY Upstate Medical University in Syracuse are developing lab-grown insulin-producing cells as a possible ...
Dr. Beaston brings 24 years of FDA leadership experience in islet cell transplantation, cell and gene therapies, and type 1 diabetes ...
A century and a quarter after the discovery of insulin, researchers are pushing toward what they believe could be the next ...
A detailed analysis of eleven islet transplant recipients shows that donor islets begin improving glucose control within days ...
FDA-approved gene therapies for sickle cell disease offer a chance to help patients, but factors including cost and access ...
CAR-T cell therapy, approved for some blood cancers, is being studied for lupus, MS, and scleroderma. Yale Medicine experts ...
LifeMine Therapeutics Inc., a clinical-stage biopharmaceutical company pioneering Top-Down Drug Discovery™, which leverages digital genomic search technology from fungi to source next-generation ...
LifeMine Therapeutics, a Watertown, Massachusetts-based clinical-stage biopharmaceutical company, has established a clinical advisory board of eight organ transplantation specialists to... Read More ...
A protective coating prolonged the survival and function of transplanted islet cells in diabetic mice, offering a novel cell ...
Advances in three key areas are leading to a paradigm shift in type 1 diabetes treatment and research, according to a speaker ...
The pancreas is a complex organ comprising multiple cell types that regulate blood glucose levels through hormones, such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results